Duke Herrell, MD

Why follow Duke

Duke Herrell is CEO at Virtuoso Surgical. Virtuoso Surgical's official announcement states that FDA granted De Novo authorization to the Virtuoso Endoscopy System on October 30, 2026. It is the first device in a new classification, electromechanical surgical systems for endoluminal surgical procedures. Two small robotic arms at the tip of a rigid endoscope support en bloc resection of bladder lesions. A focused U.S. launch at leading urology centers is planned for 2027. Duke Herrell, MD is CEO. Authorization, planned launch and availability are distinct.